Features of the Intestinal and Respiratory Microbiome in Colorectal Cancer Patients in Western Siberia
Authors:
- Vladimir G. DruzhininVDVladimir G. Druzhinin
- Elizaveta D. BaranovaEBElizaveta D. Baranova
- Pavel S. DemenkovPDPavel S. Demenkov
- Alexey S. ZhivotovskiyAZAlexey S. Zhivotovskiy
- Liudmila V. MatskovaLiudmila V. Matskova
- Aleksey V. LarionovAleksey V. Larionov
- Kirill S. AvdeevKAKirill S. Avdeev
- Arseniy E. YuzhalinArseniy E. Yuzhalin
Open Access
- 23 June 2026
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1392
Abstract
To perform the first concurrent characterization of gut and respiratory microbiome profiles in colorectal cancer patients from Western Siberia, Russia. We analyzed synchronous fecal and sputum samples from 40 treatment-naive colorectal cancer patients and 45 healthy controls using 16S rRNA gene (V3-V4) sequencing and QIIME 2-based bioinformatic workflows. While alpha-diversity indices did not differ significantly between groups, beta-diversity analysis revealed substantial compositional differences for both ecosystems. Colorectal cancer patients exhibited gut enrichment of Proteobacteria, Fusobacteria, Fusobacterium, Odoribacter, Lachnospiraceae_UCG-010, Erysipelatoclostridium, Parvimonas, Finegoldia, Clostridium and Bacteroides (Bacteroides fragilis), alongside sputum enrichment of phyla Bacteroidetes and Actinobacteria, as well as genera Neisseria, Prevotella, Lactobacillus, Rothia, Nocardia, Leptotrichia, Campylobacter, and Helicobacter. Stage-associated shifts included elevated Akkermansia in gut microbiomes of patients with advanced-stage disease and higher Campylobacter in early-stage sputum. These findings identify distinct gut–respiratory dysbiotic signatures in a previously understudied population. Our results underscore the potential of dual-compartment microbiome profiling for developing non-invasive biomarkers and require validation in larger, multicenter cohorts to elucidate mechanistic links between respiratory dysbiosis and colorectal carcinogenesis.Keywords
Funding Information
- Russian Science Foundation (25-15-20012)
- Ministry of Education of Kuzbass (02/2025)
This publication has 49 references indexed in Scilit:
- Western diet-based NutriCol medium: A high-pectin, low-inulin culture medium promoted gut microbiota stability and diversity in PolyFermS and M-ARCOL continuous in vitro modelsFood Research International, 2025
- Helicobacter pylori in oral cavity: current knowledgeClinical and Experimental Medicine, 2024
- Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: A systematic review and meta-analysisMicrobial Pathogenesis, 2024
- Multi-cohort analysis of depression-associated gut bacteria sheds insight on bacterial biomarkers across populationsCellular and Molecular Life Sciences, 2022
- Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancerTrends in Microbiology, 2022
- Exploring the Role of Gut Microbiome in Colon CancerApplied Biochemistry and Biotechnology, 2021
- The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?Clinical Colorectal Cancer, 2020
- Microbiome and Colorectal CancerCurrent Colorectal Cancer Reports, 2018
- Next-generation sequencing applications in clinical bacteriologyBiomolecular Detection and Quantification, 2017
- Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune MicroenvironmentCell Host & Microbe, 2013